BioMed X & Merck Advance Precision Oncology with New Research Breakthrough

The independent research organization BioMed X has finalized its oncology research initiative in collaboration with Merck, whose data has been obtained by Merck for additional development, possibly resulting in innovative therapeutic methods in...

How Early Detection is Transforming Cancer Treatment in India

In a webinar by ASSOCHAM on revolutionizing early cancer detection, Malti Sachdev, Head, Varian India shares her views on the relevance of taking cancer treatment in the early detection stages and the mindset to shift from fear to empowerment...

Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug

Dr. Reddy's Laboratories announced that its subsidiary has signed a licensing agreement with Shanghai Henlius Biotech, Inc. to develop and market a cancer drug currently in development. Dr Reddy's Laboratories SA has signed an agreement with the...

Algiax Pharma Reports Promising Phase 2a Results for AP-325

Algiax Pharmaceuticals, a biotech company in the clinical stage that specializes in creating innovative therapies for chronic neuropathic pain, revealed promising topline results from its phase 2a clinical trial assessing AP-325 for neuropathic...

Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation

Sigachi Industries Limited, a prominent entity in the pharmaceutical sector, is setting up a research and development center in Hyderabad, unifying its essential API Innovation and analytical initiatives in one location. This strategic plan...

Akums Combines Two Potent Diabetes Medicines for Enhanced Treatment Efficacy

Akums Drugs and Pharmaceuticals, a leader in contract development and manufacturing, has launched Dapagliflozin + Pioglitazone tablets; an advanced combination therapy designed to tackle the growing challenge of diabetes management...

Onco-Innovations Unveils PNKP Inhibitors to Enhance Cancer Treatment Efficacy

Onco-Innovations Limited, a Canadian firm focused on cancer research and treatment, specializing in oncology, has shared details about its licensed technology involving a novel class of PNKP (Polynucleotide Kinase 3'-Phosphatase) inhibitors...

Telix Pharma Concludes Acquisition of Antibody Engineering Firm ImaginAb

Telix Pharmaceuticals Limited, a biopharmaceutical firm dedicated to the advancement and marketing of therapeutic and diagnostic radiopharmaceuticals alongside related medical technologies, declared that it has finalized the acquisition from the...

Phytopharmaceuticals: Driving Global Herbal Medicine Innovation

In the GGSCOP National Conference on Advancing Pharmaceutical Research, Dr. Zabeer Ahmed, Director, CSIR-IIIM Jammu, shares his views on the importance of merging traditional medicinal knowledge with advanced scientific methods and regulatory...

Quantum-Si & IDEX Health Partner to Advance Proteus Proteomics Platform

Quantum-Si Incorporated, the protein sequencing firm, and IDEX Health & Science, LLC, announced a collaboration to develop and manufacture the optics module for Quantum-Si's innovative proteomics platform, Proteus. IDEX Health & Science, LLC...

© 2025 India Pharma Outlook. All Rights Reserved.

Safety Monitoring